Get an inside look at how biopharma market access leaders are viewing the current state of affairs in the industry in regards to patients, payers, and regulators with this article from In Vivo. In concert with the Boston Consulting Group (BCG), In Vivo convened a gathering of more than 20 biopharma leaders to discuss where the industry stands today, and how it may be adapting to new innovations in market access in the future. Find out what the leaders had to say in these informative excerpts of their opinions.